A Phase 1, Three-part, Part-randomised, Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Different Formulations of Tricaprilin, to Include Single-dose, Food Effect, and Titration Tolerability, in Healthy Participants
Latest Information Update: 01 Apr 2026
At a glance
- Drugs Tricaprilin (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Cerecin
Most Recent Events
- 01 Apr 2026 New trial record